Sales decline 77.44% to Rs 5.56 crore
Net profit of Shukra Pharmaceuticals declined 88.54% to Rs 0.54 crore in the quarter ended September 2024 as against Rs 4.71 crore during the previous quarter ended September 2023. Sales declined 77.44% to Rs 5.56 crore in the quarter ended September 2024 as against Rs 24.64 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales5.5624.64 -77 OPM %12.0520.62 -PBDT1.585.26 -70 PBT0.884.70 -81 NP0.544.71 -89Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Donald Trump, Trump")
 "Bluesky logo")
 "Truck")
 "Xi Jinping, Jinping, China President")
 "Pollution, New Delhi Pollution")
